Cargando…

Coating with Autologous Plasma Improves Biocompatibility of Mesh Grafts In Vitro: Development Stage of a Surgical Innovation

Purpose. To investigate mesh coating modalities with autologous blood components in a recently developed in vitro test system for biocompatibility assessment of alloplastic materials. Materials and Methods. Seven different mesh types, currently used in various indications, were randomly investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerullis, Holger, Georgas, Evangelos, Eimer, Christoph, Arndt, Christian, Barski, Dimitri, Lammers, Bernhard, Klosterhalfen, Bernd, Borós, Mihaly, Otto, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789305/
https://www.ncbi.nlm.nih.gov/pubmed/24151608
http://dx.doi.org/10.1155/2013/536814
_version_ 1782286430477746176
author Gerullis, Holger
Georgas, Evangelos
Eimer, Christoph
Arndt, Christian
Barski, Dimitri
Lammers, Bernhard
Klosterhalfen, Bernd
Borós, Mihaly
Otto, Thomas
author_facet Gerullis, Holger
Georgas, Evangelos
Eimer, Christoph
Arndt, Christian
Barski, Dimitri
Lammers, Bernhard
Klosterhalfen, Bernd
Borós, Mihaly
Otto, Thomas
author_sort Gerullis, Holger
collection PubMed
description Purpose. To investigate mesh coating modalities with autologous blood components in a recently developed in vitro test system for biocompatibility assessment of alloplastic materials. Materials and Methods. Seven different mesh types, currently used in various indications, were randomly investigated. Meshes were coated prior to cultivation with autologous peripheral blood mononuclear cells (PBMCs), platelets, and blood plasma. Pretreated meshes were incubated over 6 weeks in a minced tissue assay, representative for fibroblasts, muscle cells, and endothelial cells originating from 10 different patients. Adherence of those tissues on the meshes was microscopically investigated and semiquantitatively assessed using a previously described scoring system. Results. Coating with peripheral blood mononuclear cells did not affect the adherence score, whereas coating with platelets and blood plasma increased the score suggesting improved biocompatibility in vitro. The previous ranking of native meshes remained consistent after coating. Conclusion. Plasma coating of meshes improves their biocompatibility score in a novel in vitro test system.
format Online
Article
Text
id pubmed-3789305
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37893052013-10-22 Coating with Autologous Plasma Improves Biocompatibility of Mesh Grafts In Vitro: Development Stage of a Surgical Innovation Gerullis, Holger Georgas, Evangelos Eimer, Christoph Arndt, Christian Barski, Dimitri Lammers, Bernhard Klosterhalfen, Bernd Borós, Mihaly Otto, Thomas Biomed Res Int Research Article Purpose. To investigate mesh coating modalities with autologous blood components in a recently developed in vitro test system for biocompatibility assessment of alloplastic materials. Materials and Methods. Seven different mesh types, currently used in various indications, were randomly investigated. Meshes were coated prior to cultivation with autologous peripheral blood mononuclear cells (PBMCs), platelets, and blood plasma. Pretreated meshes were incubated over 6 weeks in a minced tissue assay, representative for fibroblasts, muscle cells, and endothelial cells originating from 10 different patients. Adherence of those tissues on the meshes was microscopically investigated and semiquantitatively assessed using a previously described scoring system. Results. Coating with peripheral blood mononuclear cells did not affect the adherence score, whereas coating with platelets and blood plasma increased the score suggesting improved biocompatibility in vitro. The previous ranking of native meshes remained consistent after coating. Conclusion. Plasma coating of meshes improves their biocompatibility score in a novel in vitro test system. Hindawi Publishing Corporation 2013 2013-09-17 /pmc/articles/PMC3789305/ /pubmed/24151608 http://dx.doi.org/10.1155/2013/536814 Text en Copyright © 2013 Holger Gerullis et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gerullis, Holger
Georgas, Evangelos
Eimer, Christoph
Arndt, Christian
Barski, Dimitri
Lammers, Bernhard
Klosterhalfen, Bernd
Borós, Mihaly
Otto, Thomas
Coating with Autologous Plasma Improves Biocompatibility of Mesh Grafts In Vitro: Development Stage of a Surgical Innovation
title Coating with Autologous Plasma Improves Biocompatibility of Mesh Grafts In Vitro: Development Stage of a Surgical Innovation
title_full Coating with Autologous Plasma Improves Biocompatibility of Mesh Grafts In Vitro: Development Stage of a Surgical Innovation
title_fullStr Coating with Autologous Plasma Improves Biocompatibility of Mesh Grafts In Vitro: Development Stage of a Surgical Innovation
title_full_unstemmed Coating with Autologous Plasma Improves Biocompatibility of Mesh Grafts In Vitro: Development Stage of a Surgical Innovation
title_short Coating with Autologous Plasma Improves Biocompatibility of Mesh Grafts In Vitro: Development Stage of a Surgical Innovation
title_sort coating with autologous plasma improves biocompatibility of mesh grafts in vitro: development stage of a surgical innovation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789305/
https://www.ncbi.nlm.nih.gov/pubmed/24151608
http://dx.doi.org/10.1155/2013/536814
work_keys_str_mv AT gerullisholger coatingwithautologousplasmaimprovesbiocompatibilityofmeshgraftsinvitrodevelopmentstageofasurgicalinnovation
AT georgasevangelos coatingwithautologousplasmaimprovesbiocompatibilityofmeshgraftsinvitrodevelopmentstageofasurgicalinnovation
AT eimerchristoph coatingwithautologousplasmaimprovesbiocompatibilityofmeshgraftsinvitrodevelopmentstageofasurgicalinnovation
AT arndtchristian coatingwithautologousplasmaimprovesbiocompatibilityofmeshgraftsinvitrodevelopmentstageofasurgicalinnovation
AT barskidimitri coatingwithautologousplasmaimprovesbiocompatibilityofmeshgraftsinvitrodevelopmentstageofasurgicalinnovation
AT lammersbernhard coatingwithautologousplasmaimprovesbiocompatibilityofmeshgraftsinvitrodevelopmentstageofasurgicalinnovation
AT klosterhalfenbernd coatingwithautologousplasmaimprovesbiocompatibilityofmeshgraftsinvitrodevelopmentstageofasurgicalinnovation
AT borosmihaly coatingwithautologousplasmaimprovesbiocompatibilityofmeshgraftsinvitrodevelopmentstageofasurgicalinnovation
AT ottothomas coatingwithautologousplasmaimprovesbiocompatibilityofmeshgraftsinvitrodevelopmentstageofasurgicalinnovation